NASDAQ:NAMS | Cash Flow Statement | NewAmsterdam Pharma Co N.V.

Complete source-backed cash-flow history.

Available history
2021-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$64.14M
2026-03-31-$48.44M$62,000.00-$30.6M-$11.51M$11.07M
2025-12-31-$74.92M$59,000.00-$40.88M-$21.14M$13.68M
2025-09-30-$72.01M
2025-06-30-$17.36M
2025-03-31-$39.53M$52,000.00-$36.47M$2.86M$6.52M
2024-12-31-$92.18M$51,000.00-$37.48M-$62.18M$456.61M
2024-09-30-$16.65M
2024-06-30-$39.01M
2024-03-31-$93.77M$15,000.00-$54.6M-$385,000.00$198.18M
2023-12-31-$49.5M$13,000.00-$33.07M-$3,000.00$0.00
2023-09-30-$47.13M
2023-06-30-$38.29M
2023-03-31-$42.02M$9,000.00-$31.86M-$7,000.00$2.39M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$203.82M$220,000.00-$147.78M-$174.92M$29.52M
2024-12-31-$241.6M$113,000.00-$158.56M-$62.85M$659.51M
2023-12-31-$176.94M$49,000.00-$141.22M-$24,000.00$8.91M
2022-12-31-$22.63M$9,000.00$10.67M-$221,000.00$391.91M
2021-12-31-$41.79M$5,000.00-$29.51M-$24,000.00$84.7M